Furthermore, NRF2 induces macropinocytosis and contributes to the escape of autophagy-deficient cancer cells from metabolic decline and anticancer drugs, such as gemcitabine and doxorubicin, which target the anabolic dependencies of cancer cells [72,73]. This evidence concerns the gene NFE2L2 and cancer.